This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Review

. 1992 Jan-Feb;9(1):9-14.

doi: 10.1111/j.1464-5491.1992.tb01707.x.

Diabetic macrovascular disease and serum lipids: is there a connection?

P K Merrin¹, M D Feher, R S Elkeles

Affiliations

PMID: 1551316
DOI: 10.1111/j.1464-5491.1992.tb01707.x

Review

Diabetic macrovascular disease and serum lipids: is there a connection?

P K Merrin et al. Diabet Med. 1992 Jan-Feb.

. 1992 Jan-Feb;9(1):9-14.

doi: 10.1111/j.1464-5491.1992.tb01707.x.

Authors

P K Merrin¹, M D Feher, R S Elkeles

Affiliation

¹ Unit of Metabolic Medicine, St Mary's Hospital, London, UK.

PMID: 1551316
DOI: 10.1111/j.1464-5491.1992.tb01707.x

No abstract available

PubMed Disclaimer

Similar articles

Risk factors for macrovascular disease in type 2 diabetes. Classic lipid abnormalities.
Steiner G. Steiner G. Diabetes Care. 1999 Apr;22 Suppl 3:C6-9. Diabetes Care. 1999. PMID: 10189556 Review. No abstract available.
Serum cholesterol binding reserve percentage in diabetes mellitus.
Ghatak A, Bhatia KB, Chandra A, Kapoor NK. Ghatak A, et al. Acta Diabetol Lat. 1985 Jul-Sep;22(3):253-8. doi: 10.1007/BF02590777. Acta Diabetol Lat. 1985. PMID: 3865475
[Diabetic patients with heart disease. Especially strict blood values are important here].
Standl E. Standl E. MMW Fortschr Med. 2006 Oct 12;148(41):11. MMW Fortschr Med. 2006. PMID: 17190249 German. No abstract available.
Advanced glycation end products and coronary heart disease in type 2 diabetes.
Poirier P, Eckel RH. Poirier P, et al. Diabetes Care. 2000 Sep;23(9):1441-2. doi: 10.2337/diacare.23.9.1441. Diabetes Care. 2000. PMID: 10977055 No abstract available.
Homocysteine concentrations in patients with diabetes mellitus--relationship to microvascular and macrovascular disease.
Elias AN, Eng S. Elias AN, et al. Diabetes Obes Metab. 2005 Mar;7(2):117-21. doi: 10.1111/j.1463-1326.2004.00376.x. Diabetes Obes Metab. 2005. PMID: 15715884 Review. No abstract available.

See all similar articles

Cited by

Comparative tolerability profiles of oral antidiabetic agents.
Krentz AJ, Ferner RE, Bailey CJ. Krentz AJ, et al. Drug Saf. 1994 Oct;11(4):223-41. doi: 10.2165/00002018-199411040-00002. Drug Saf. 1994. PMID: 7848543 Review.
Asymptomatic coronary artery disease in diabetes: relation to common risk factors, lipoproteins, apoproteins and apo E polymorphism.
Koistinen MJ, Huikuri HV, Korhonen UR, Linnaluoto MK, Kuusi T, Takkunen JT, Taskinen MR. Koistinen MJ, et al. Acta Diabetol. 1994 Dec;31(4):210-4. doi: 10.1007/BF00571953. Acta Diabetol. 1994. PMID: 7888691
Increased hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 in NIDDM.
Cummings MH, Watts GF, Umpleby AM, Hennessy TR, Naoumova R, Slavin BM, Thompson GR, Sönksen PH. Cummings MH, et al. Diabetologia. 1995 Aug;38(8):959-67. doi: 10.1007/BF00400586. Diabetologia. 1995. PMID: 7589883

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Medical
- MedlinePlus Health Information